综合应激反应在药物诱导的二次性 dystonia 的参与
Tricia A Simon1, Sanjana B Parise1, Natalie E Jackson1
1University of South Carolina, Columbia, South Carolina 29208, United States.
ACS omega
|November 3, 2025
概括
抗精神病药物触发了综合应激反应 (ISR) 途径,导致药物诱导的抑郁症. 化合物黄素可能有助于抑制这种ISR,潜在地预防或治疗这种情况.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 遗传性原发性 dystonia 涉及一个不适应的综合应激反应 (ISR) 和失调的真核转化启动因子α (eIF2α) 信号传递.
- 作为抗精神病和抗药物的副作用,二次性 dystonia 背后的分子途径仍然没有表征.
研究的目的:
- 调查ISR通路对药物诱导的 dystonia 的贡献.
- 确定抗精神病药物诱导ISR的分子机制,并探索潜在的治疗干预措施.
主要方法:
- 来自小鼠神经母细胞瘤的Neuro-2a (N2a) 细胞在报告的血度下被用八种已知诱导 dystonia 的抗精神病药物治疗.
- 西方斑点分析被用来检测ISR诱导,而共免疫沉试验评估了蛋白激酶,RNA激活 (PKR) 和PKR激活器 (PACT) 的参与.
- 评估了黄素破坏PACT-PKR相互作用和抑制ISR诱导的能力.
主要成果:
- 发现抗精神病药物通过激活PKR类的内 плазма网膜居民激酶 (PERK) 和PKR来诱导ISR,从而导致eIF2α酸化.
- 观察到PACT在药物暴露时与PKR结合,导致PKR激活.
- 氨酸证明了破坏PACT-PKR相互作用的能力,从而抑制ISR诱导.
结论:
- ISR诱导被确定为二次药物诱导的 dystonia 的新病理机制.
- 丁显示出作为一种治疗剂的潜力,可以抑制ISR,减轻或预防抗精神病药物引起的二次性心脏.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.1K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.1K
Desensitization and Tachyphylaxis
3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K
Skeletal Muscle Relaxants: Adverse Effects
767
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
767
Hypothalamic-Pituitary Axis
65.4K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
65.4K
Centrally Acting Muscle Relaxants: Therapeutic Uses
1.2K
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
1.2K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K


